Continuum Health Communications

06/26/2018

Great to see WEGO Health David Goldsmith work with Ilyssa Levins at CCC on indepth commentary re: PFDD

The 21st Century Cures Act (Cures Act), which was passed by Congress, includes mandates to provide the U.S. Food and Drug Administration (FDA) with resources to modernize the Agency’s scientific and regulatory programs. Patient-focused drug development (PFDD) is one of the strategies. The Cures Ac...

06/25/2018

Clinuvel submits Scenesse NDA to FDA.

A New Drug Application (NDA) for the treatment of erythropoietic protoporphyria (EPP) – a rare blood disorder in which patients experience severe biochemical reactions following light exposure – has been submitted to the Food and Drug Administration (FDA).

06/11/2018

WEGO Health David Goldsmith get the real answers from real patient leaders when FiercePharma asks what patients really think about the Roseanne debacle and Sanofi's response.

Sanofi scored plenty of attention with its Twitter pushback against actress Roseanne Barr, who blamed its sleep aid Ambien for her own racist post. But did that viral tweet boost Sanofi and the Ambien brand? Patient gurus and social media analysts have some answers.

05/25/2018

Nice write up in Xconomy for Strata Oncology on how Series B will be allocated and StrataNGS use expanded.

In what company leaders describe as a “huge step,” Ann Arbor, MI-based precision medicine startup Strata Oncology this week closed a $26 million Series B i

05/24/2018

A nice tip of the hat to in Series B with Merck and Pfizer Inc. VCs leading round

The VC wings of Merck and Pfizer have led a $26 million series B investment in Strata Oncology. Raising the cash sets Strata up to file for approval of a tumor molecular profiling assay while building out its platform and the network of health centers that use its technology.

05/24/2018

Adamas Pharma data published in Clinical Pharmacokinetics show effective once daily dosing at bedtime for dyskinesia in Parkinson's patients.

EMERYVILLE, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that pharmacokinetic (PK) data regarding GOCOVRI™ (amantadine) extended release capsules were published online in Clinical Pharmacokinetics. The paper, entitled Pharmacokinetics of ADS-5...

05/16/2018

Zephyr Health CEO William King talk Health IT in today's pharma landscape

I first spoke with William for our Entrepreneur Journeys series in March 2015. This is a follow-up discussion on the company's progress and extensive impact by harnessing data from a hundred different sources to help pharmaceutical companies across various use cases. Excellent insights! Sramana Mitr...

05/14/2018

Glad to see Zephyr Health Leilani Latimer in the AI and Machine learning debate!

05/14/2018

WEGO Health Jack Barrette reveal the real power behind go-to-market strategy in pharma http://ow.ly/pAnL30jZdZ6

How “patient influencers” look beyond price to help the industry evaluate newly-launched brands.

05/14/2018

WEGO HealthDavid Goldsmith weigh in on crowdsourcing http://ow.ly/rrWw30jZdIZ

Crowdsourcing healthcare innovation can lead to rapid and often unforeseen developments.

05/03/2018

is laser-focused on patient insights that come from the right POLs (Patient Opinion Leaders). Listen to this podcast: http://ow.ly/SK9J30jPdxh

03/26/2018

I am so honored to have worked with Multiple Myeloma RF and be able to call Kathy Giusti a friend. The word admiration doesn't do it justice. More like in awe.

In 1996, Kathy Giusti, then a 37-year-old pharmaceutical sales exec with a new baby, was told she had blood cancer, multiple myeloma, and three years to live. She refused to act like her life was over.